Bio-Rad Labs (BIO) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 --0%
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $551.5 million versus the consensus estimate of $527.2 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Goldman Sachs Assumes Klaviyo Inc (KVYO) at Buy
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
